Véronique Vergé

469 total citations
20 papers, 125 citations indexed

About

Véronique Vergé is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Véronique Vergé has authored 20 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Véronique Vergé's work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Véronique Vergé is often cited by papers focused on CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Véronique Vergé collaborates with scholars based in France, Vietnam and Lebanon. Véronique Vergé's co-authors include Hua Cao, Norbert Claude Gorin, M. Lopez, Suzy Scholl, Jean Salamero, A. Léon, Chantal Martinache, Carole Baron, Jacky Bernard and Luc Douay and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Véronique Vergé

16 papers receiving 123 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Véronique Vergé France 6 81 47 40 21 12 20 125
Kenichi Ishiyama Japan 7 51 0.6× 45 1.0× 44 1.1× 25 1.2× 8 0.7× 12 125
Ilse Houtenbos Netherlands 10 145 1.8× 51 1.1× 100 2.5× 31 1.5× 15 1.3× 20 216
Chonghai Liu Sweden 5 154 1.9× 65 1.4× 26 0.7× 27 1.3× 9 0.8× 7 204
John C. Byrd United States 5 57 0.7× 69 1.5× 43 1.1× 27 1.3× 19 1.6× 10 142
Suet Ling Felce United Kingdom 7 43 0.5× 83 1.8× 36 0.9× 8 0.4× 19 1.6× 7 135
Elena M. Cortizas United States 6 74 0.9× 103 2.2× 46 1.1× 9 0.4× 18 1.5× 8 172
Tomalika R. Ullah Australia 5 55 0.7× 75 1.6× 58 1.4× 51 2.4× 13 1.1× 6 143
Thomas Altmann United Kingdom 3 79 1.0× 66 1.4× 35 0.9× 16 0.8× 7 0.6× 4 152
Anahita Rafiei Switzerland 5 50 0.6× 38 0.8× 38 0.9× 49 2.3× 8 0.7× 8 122
Nina Lanzarotti France 3 139 1.7× 51 1.1× 33 0.8× 18 0.9× 12 1.0× 3 166

Countries citing papers authored by Véronique Vergé

Since Specialization
Citations

This map shows the geographic impact of Véronique Vergé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Vergé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Vergé more than expected).

Fields of papers citing papers by Véronique Vergé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Vergé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Vergé. The network helps show where Véronique Vergé may publish in the future.

Co-authorship network of co-authors of Véronique Vergé

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Vergé. A scholar is included among the top collaborators of Véronique Vergé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Vergé. Véronique Vergé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vergé, Véronique, Arnaud Pagès, Vincent Ribrag, et al.. (2025). CAR T cell–mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis. Science Translational Medicine. 17(817). eadu9790–eadu9790.
2.
Pagès, Arnaud, Véronique Vergé, Cyril Quivoron, et al.. (2024). 803MO CAR T cells reside in the bone marrow and inhibits healthy hematopoiesis. Annals of Oncology. 35. S597–S598.
3.
Quivoron, Cyril, Jean‐Marie Michot, Alina Danu, et al.. (2024). Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study. Leukemia & lymphoma. 65(6). 789–799. 3 indexed citations
4.
Saleh, Khalil, David Ghez, Camille Bigenwald, et al.. (2023). Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation. Immunotherapy. 15(6). 401–407. 2 indexed citations
5.
Quivoron, Cyril, Jean‐Marie Michot, Arnaud Pagès, et al.. (2022). Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma. Haematologica. 107(8). 1928–1932. 2 indexed citations
6.
Quivoron, Cyril, Jean‐Marie Michot, Julien Lazarovici, et al.. (2021). Molecular Profiling Feasibility on Cell-Free Tumoral DNA in Relapse/Refractory (R/R) Multiple Myeloma (MM) Patients Screened for Phase I Trials. Blood. 138(Supplement 1). 3763–3763. 1 indexed citations
7.
Quivoron, Cyril, Jean‐Marie Michot, Valérie Camara‐Clayette, et al.. (2020). High Incidence of TP53 and Epigenetic Modifying Oncogenes Mutations in a Large Cohort of Patients Enrolled in Phase 1 Clinical Trials for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Blood. 136(Supplement 1). 10–11. 1 indexed citations
8.
Rassy, Elie, Alina Danu, Tony Ibrahim, et al.. (2020). Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy Experience. Clinical Lymphoma Myeloma & Leukemia. 21(4). e373–e380. 5 indexed citations
9.
Lerner, Letícia Koch, Vy Nguyen, Veridiana Munford, et al.. (2020). Large deletions in immunoglobulin genes are associated with a sustained absence of DNA Polymerase η. Scientific Reports. 10(1). 1311–1311. 7 indexed citations
10.
Vergé, Véronique, et al.. (2020). COVID-19–induced atypical pulmonary lymphocytes. Blood. 136(19). 2241–2241. 2 indexed citations
11.
Hueso, Thomas, Stéphanie Foulon, Laurence Albigès, et al.. (2020). Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID‐19. British Journal of Haematology. 192(3). e87–e90. 1 indexed citations
12.
Vergé, Véronique, et al.. (2019). Bone marrow metastases mimicking acute leukaemia. British Journal of Haematology. 187(5). 556–556. 2 indexed citations
13.
Ibrahim, Tony, Tarek Assi, Julien Lazarovici, et al.. (2018). Non-Effectiveness of Using RICE Post RDHAP or RDHAP Post RICE after Failure of First Line Salvage Therapy in DLBCL Patients Who Are Eligible for ASCT. Blood. 132(Supplement 1). 4226–4226.
14.
15.
Danu, Alina, Sophie Cotteret, Ludovic Lacroix, et al.. (2016). BRAF V600E Targetable Mutation in Relapsed/Refractory Multiple Myeloma (R/R MM) Patients: A High Incidence in R/R MM Detected Using Cell Sorting Screening. Blood. 128(22). 5638–5638. 2 indexed citations
16.
Annereau, Maxime, Julien Lazarovici, Véronique Saada, et al.. (2014). Results of treatment with 5-azacytidine in patients treated for myelodysplastic syndrome or secondary acute myeloid leukemia associated with a concomitant active cancer.. Journal of Clinical Oncology. 32(15_suppl). e18029–e18029. 1 indexed citations
17.
Garderet, Laurent, Hua Cao, Jean Salamero, et al.. (2001). In Vitro Production of Dendritic Cells from Human Blood Monocytes for Therapeutic Use. Journal of Hematotherapy & Stem Cell Research. 10(4). 553–567. 24 indexed citations
18.
Cao, Hua, Véronique Vergé, Carole Baron, et al.. (2000). Cutting Edge Communication: In Vitro Generation of Dendritic Cells from Human Blood Monocytes in Experimental Conditions Compatible for In Vivo Cell Therapy. Journal of Hematotherapy & Stem Cell Research. 9(2). 183–194. 43 indexed citations
19.
Giarratana, Marie‐Catherine, Véronique Vergé, Christian Schmitt, et al.. (2000). Presence of primitive lymphoid progenitors with NK or B potential in ex vivo expanded bone marrow cell cultures. Experimental Hematology. 28(1). 46–54. 20 indexed citations
20.
Zou, Gang‐Ming, et al.. (2000). Fas‐Mediated Apoptosis of Mouse Embryo Stem Cells: Its Role During Embryonic Development. American Journal of Reproductive Immunology. 43(4). 240–248. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenichi Ishiyama Breakdown of academic impact, for papers by Ilse Houtenbos Breakdown of academic impact, for papers by Chonghai Liu Breakdown of academic impact, for papers by John C. Byrd Breakdown of academic impact, for papers by Suet Ling Felce Breakdown of academic impact, for papers by Elena M. Cortizas Breakdown of academic impact, for papers by Tomalika R. Ullah Breakdown of academic impact, for papers by Thomas Altmann Breakdown of academic impact, for papers by Anahita Rafiei Breakdown of academic impact, for papers by Nina Lanzarotti
Rankless by CCL
2026